| Functional Genomics to Guide Cancer Drug Discovery | |||||
|
Tue23 Mar11:05am(45 mins)
|
|
|
Mathew Garnett | ||
| Session : Functional Genomics | |||||
| Room: Conference Hall | |||||
| CRISPR screening to identify new drug targets in complex cell models | |||||
|
Tue23 Mar11:50am(30 mins)
|
|
|
Dr Carlos le Sage | ||
| Session : Functional Genomics | |||||
| Room: Conference Hall | |||||
| Session Chair Welcome | |||||
|
Tue23 Mar01:20pm(5 mins)
|
|
Dr Andrew Bassett | |||
| Session : Functional Genomics | |||||
| Room: Conference Hall | |||||
| Using CRISPR/Cas9 screens to study epidermal keratinocyte differentiation and inflammation | |||||
|
Tue23 Mar01:25pm(20 mins)
|
|
Dr Christopher Bryant | |||
| Session : Functional Genomics | |||||
| Room: Conference Hall | |||||
| Multilayered VBC score predicts sgRNAs that efficiently generate loss-of-function alleles | |||||
|
Tue23 Mar01:45pm(20 mins)
|
|
|
Ulrich Elling | ||
| Session : Functional Genomics | |||||
| Room: Conference Hall | |||||
| Joint Q&A Session | |||||
|
Tue23 Mar02:05pm(20 mins)
|
|
Mathew Garnett |
|
Dr Christopher Bryant | |
|
|
Ulrich Elling | ||||
| Session : Functional Genomics | |||||
| Room: Conference Hall | |||||
| FirePlex Multiplexed Assay Technology – a Cell-line Profiling Tool | |||||
|
Tue23 Mar02:25pm(15 mins)
|
|
|
Zeev Gechtman | ||
| Session : Functional Genomics | |||||
| Room: Conference Hall | |||||
| Screening for functional transcriptional and splicing regulatory variants with GenIE | |||||
|
Tue23 Mar03:00pm(20 mins)
|
|
|
Dr Sarah Cooper | ||
| Session : Functional Genomics | |||||
| Room: Conference Hall | |||||
| CRISPR/Cas9 - from functional genomics applications to therapeutic genome editing | |||||
|
Tue23 Mar03:20pm(20 mins)
|
|
|
Dr Lars Steinmetz | ||
| Session : Functional Genomics | |||||
| Room: Conference Hall | |||||
| CRISPR Tools to Mitigate Attrition Rate Risk in Drug Development | |||||
|
Tue23 Mar03:40pm(15 mins)
|
|
|
Dr Kai Wilkens | ||
| Session : Functional Genomics | |||||
| Room: Conference Hall | |||||
| Ultra-high throughput single-cell RNA sequencing and perturbation screening by combinatorial fluidic indexing | |||||
|
Tue23 Mar04:15pm(20 mins)
|
|
|
Dr Paul Datlinger | ||
| Session : Functional Genomics | |||||
| Room: Conference Hall | |||||
| A single-cell CRISPR screen in >100k primary human T cells | |||||
|
Tue23 Mar04:35pm(5 mins)
|
|
|
Dr Tilmann Buerckstuemmer | ||
| Session : Functional Genomics | |||||
| Room: Conference Hall | |||||
| Advanced iPSC technologies for neurodegenerative disease research | |||||
|
Tue23 Mar04:40pm(20 mins)
|
|
|
Michael Ward | ||
| Session : Functional Genomics | |||||
| Room: Conference Hall | |||||
| Joint Q&A Session | |||||
|
Tue23 Mar05:00pm(20 mins)
|
|
Michael Ward |
|
Dr Lars Steinmetz | |
|
|
Dr Sarah Cooper |
|
Dr Paul Datlinger | ||
| Session : Functional Genomics | |||||
| Room: Conference Hall | |||||
